Multiple endocrine neoplasia type 1: Atypical presentation, clinical course, and genetic analysis of multiple tumors

Modern Pathology

Volumn 12, Issue 9, 1999, Pages 919-924

  Vortmeyer, Alexander O ^a   Lubensky, Irina A ^a   Skarulis, Monica ^b   Li, Guang ^a   Moon, Young Wan ^c   Park, Won Sang ^a   Weil, Robert ^a   Barlow, Carrolee ^b   Spiegel, Allen M ^b   Marx, Stephen J ^b   Zhuang, Zhengping ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Hallym University   (South Korea)

Author keywords

Adrenal cortical hyperplasia; Hepatic focal nodular hyperplasia; Leiomyoma; Loss of heterozygosity; MEN1; Neuroendocrine tumors; Thyroid neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CASE REPORT; CLINICAL FEATURE; CUSHING SYNDROME; DISEASE COURSE; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; LEIOMYOMA; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NODULAR HYPERPLASIA; PRIORITY JOURNAL; THYROID TUMOR;

ADULT; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LEIOMYOMA; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PARATHYROID NEOPLASMS; PROTO-ONCOGENE PROTEINS; THYROID NEOPLASMS;

EID: 0032846252     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988:332:85-7.
2. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276:404-7.
3. Metz DC, Jensen RT, Bale A, Skarulis MC, Eastman R, Nieman L, et al. Multiple endocrine neoplasia type 1: clinical features and management. In: Bilezekian JP, Marcus R, Levine MA, editors. The parathyroids. New York: Raven Press; 1994. p. 591-646.
4. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997;13:773-81.
5. Dong Q, Debelenko LV, Chandrasekharappa SC, Emmert-Buck MR, Zhuang Z, Guru SC, et al. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997;82:1416-20.
6. Pack S, Turner ML, Zhuang Z, Vortmeyer AO, Böni R, Skarulis M, et al. Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Dermatol 1998;110:438-41.
7. Vortmeyer AO, Boni R, Pak E, Pack S, Zhuang Z. Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas [letter]. J Natl Cancer Inst 1998;90: 398-9.
8. Larsson C, Shepherd J, Nakamura Y, Blomberg C, Weber G, Werelius B, et al. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest 1992;89:1344-9.
9. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989;321:218-24.
10. Friedman E, De Marco L, Gejman PV, Norton JA, Bale AE, Aurbach GD, et al. Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 1992;52:6804-9.
11. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, et al. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A 1990;87:1968-72.
12. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 1996;56:5272-8.
13. Weber G, Friedman E, Grimmond S, Hayward NK, Phelan C, Skogseid B, et al. The phospholipase CM gene located in the MENI region shows loss of expression in endocrine tumors. Hum Mol Genet 1994;10:1775-81.
14. Knudson AG, Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-43.
15. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997;6:1169-75.
16. Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am J Pathol 1995;146:620-5.
17. Manickam P, Guru S, Debelenko LV, Agarwal S, Olufemi S-E, Weisemann J, et al. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN 1) region. Human Genet 1997;101:102-8.
18. James MR, Richard CW 3rd, Schott JJ, Yousry C, Clark K, Bell J, et al. A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nature Genet 1994;8:70-6.
19. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997;6:2285-90.
20. Skogseid B, Larsson C, Lindgren PG, Kvanta E, Rastad J, Theodorsson E, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1992;75:76-81.